Development Partners International (DPI)

Development Partners International (DPI) is a London-based major African-focused private equity firm deploying billions across the continent, with deep sector expertise in pharmaceuticals and health facilities. Check sizes of $25M and above and a growth-stage focus place the firm at the top of the African PE market; this is a firm for category-leading African healthcare operators with substantial commercial scale, not for early-stage technology founders. The firm is not specifically AI-focused; the lens is operational scale and pan-African platform-building.

The firm’s natural fit is with African healthcare operators running revenue-scale operations across pharmaceutical manufacturing and distribution, hospital and clinic networks, diagnostics chains, and integrated care delivery platforms with proven unit economics. The right CEO profile is a seasoned operator with audited financials, a credible board, and a clear thesis on how growth capital builds a pan-African commercial champion over a 5-to-10-year hold. Pre-revenue founders, early Series A teams, and pure software AI plays are not the right fit.

Geographically, DPI’s advantage is unmatched among African PE specialists, with deep coverage across North, West, East, and Southern Africa, and credibility with global DFIs and pension fund LPs. The firm’s pattern is to back operators capable of building cross-border African platforms rather than single-country leaders. For African healthcare operators with continental ambitions, DPI is among the most credible global partners. For non-African operators, the strategic logic is thin.

The right entry path is via an investment banker leading the round, an existing growth-stage co-investor, or a senior board member with London or major African capital city growth-stage relationships. Decks should lead with audited financial history, growth metrics, market position across multiple African geographies, and a specific use of capital tied to a discrete commercial milestone. Be prepared for multi-month diligence including site visits, regulatory reviews, and management background checks.

Caveats. Growth equity from large PE funds introduces significant governance complexity, including specific protective provisions, drag-along rights, exit timing, and operational engagement expectations; engage experienced PE-track counsel from the start. African macroeconomic and FX dynamics introduce real risk into PE economics; cross-border holding structures matter. The firm’s healthcare-specific portfolio is concentrated in pharma and care delivery; for technology-led plays, dedicated venture funds are a better fit. For African healthcare operators at pan-continental growth scale, DPI is among the most credible global partners; for venture-stage technology founders or non-African operators, this is the wrong door.